Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis. [electronic resource] by
- Tremblay, Douglas
- King, Amber
- Li, Lihua
- Moshier, Erin
- Coltoff, Alexander
- Koshy, Anita
- Kremyanskaya, Marina
- Hoffman, Ronald
- Mauro, Michael J
- Rampal, Raajit K
- Mascarenhas, John
Producer: 20210428
In:
Leukemia & lymphoma vol. 61
Availability: No items available.
|
|
11.
|
Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms. [electronic resource] by
- Sapre, Manali
- Tremblay, Douglas
- Wilck, Eric
- James, Annie
- Leiter, Amanda
- Coltoff, Alexander
- Koshy, Anita G
- Kremyanskaya, Marina
- Hoffman, Ronald
- Mascarenhas, John O
- Gallagher, Emily J
Producer: 20201110
In:
Scientific reports vol. 9
Availability: No items available.
|